The Patent Finder

Cardeas Pharma Corporation

Also on record
Records under this name other than patents Cardeas Pharma Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cardeas Pharma Corporation

PatentTitleStatus Expires Confidence
US 9,526,695Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,526,696Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,526,697Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,526,698Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Dec 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 27, 2024From the USPTO record
US 9,486,462Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
Formerly held
Lapsed on the fee record
Ended Nov 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 8, 2024From the USPTO record
US 10,471,083Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Nov 12, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 12, 2023From the USPTO record
US 10,406,171Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
Lapsed on the fee record
Ended Sep 10, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 10, 2023From the USPTO record
US 8,826,904Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Sep 9, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 9, 2022From the USPTO record
US 8,820,323Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Sep 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 2, 2022From the USPTO record
US 8,636,983Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
Formerly held
Lapsed on the fee record
Ended Jan 28, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jan 28, 2018From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited